Pfizer rejected the ruling, saying it"s epilepsy drug Epanutin was a loss-making product. (Mark Lennihan/The Associated Press)
British regulators fined U.S. drugmaker Pfizer and distributor Flynn Pharma a record 89.4 million pounds ($112.7 million) Wednesday for increasing the cost of an...
Read More
